Skip to content
The Nexus
DossierENTITY

Lexapro

Coverage of Lexapro in the Nexus archive.

Earliest in view: May 5 · 13:12 UTCMost recent: Aug 17 · 09:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHAug 17 · 09:00 UTCWHYY
    I took antidepressants for more than 25 years. Getting off them was harder than I ever imagined.

    The author spent over two decades taking various antidepressants due to feelings of sadness and loneliness, eventually undergoing a difficult tapering process that resulted in severe symptoms like crying, insomnia, dizziness, and a racing heart. To manage withdrawal, she found information related to "The Maudsley Deprescribing Guidelines."

  • CRIMEJul 7 · 07:15 UTCR/SCAMS
    Fraud from work from home company [US]

    A person received a work-from-home job offer via email they don't recall applying for. They received two checks from the company, one for a sign-on bonus and courses that bounced, causing financial strain, and a second check that cannot be cashed. The individual is experiencing mental health issues and is struggling to manage bills and avoid losing their apartment and car.

  • HEALTHMay 5 · 19:32 UTCARS TECHNICA
    RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

    Robert F. Kennedy Jr. announced plans to curb prescribing of antidepressants, which he falsely compared to heroin, at a Make America Healthy Again Institute event. Mental health experts have condemned his rhetoric and are pushing back on his new efforts. The event focused on 'overmedicalization' and claims that SSRIs are prescribed without informed consent and can be harmful.

  • HEALTHMay 5 · 13:12 UTCSTAT NEWS
    STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more

    US Health and Human Services Secretary Robert F. Kennedy Jr. has announced initiatives to reduce the prescription of selective serotonin reuptake inhibitors, a class of antidepressants. Johnson & Johnson is advancing a therapy for inflammatory bowel disease into late-stage testing despite initial results not showing statistically meaningful improvement. The initiatives aim to help patients get off medications and consider non-pharmaceutical interventions.